Invention Grant
- Patent Title: Cocrystal
-
Application No.: US16074339Application Date: 2017-01-31
-
Publication No.: US10906898B2Publication Date: 2021-02-02
- Inventor: Kentaro Iwata , Yukihiro Ikeda
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Barnes & Thornburg LLP
- Priority: JP2016-017099 20160201
- International Application: PCT/JP2017/003453 WO 20170131
- International Announcement: WO2017/135259 WO 20170810
- Main IPC: C07D471/04
- IPC: C07D471/04

Abstract:
Improving the solubility of an organic compound. A cocrystal of (1) 6-ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide and (2) L-malic acid or L-tartaric acid.
Public/Granted literature
- US20200048245A1 COCRYSTAL Public/Granted day:2020-02-13
Information query